Moses Stephen, Elliott Lawrence
Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Sex Transm Dis. 2002 Dec;29(12):840-6. doi: 10.1097/00007435-200212000-00017.
There is little information in Manitoba on the utilization of drugs for sexually transmitted disease (STD) treatment and the extent to which physicians comply with STD screening and treatment guidelines. This study was undertaken to provide such information to inform policy and program development.
Physicians providing STD care were asked to complete a simple record for each new STD index client or contact seen. This information was subsequently linked with data from provincial diagnostic and treatment databases.
Between October 1997 and September 1998, there were 2535 reports of STD treatments. Only about 25% of drugs provided by the provincial health department to physicians for STD treatment could be accounted for on the basis of the treatment reports received. Seventy-four percent of all treatments provided were presumptive ones for urethral or cervical infection or pelvic inflammatory disease (PID), and 14.4% of these were associated with subsequent positive tests for Chlamydia trachomatis or Neisseria gonorrhoeae. About three quarters of presumptive treatments were in compliance with provincial guidelines, as were most etiology-based treatments for chlamydial infection and 72% of etiology-based treatments for gonorrhea. Noncompliance with guidelines was commonly due to presumptive treatment that covered only C trachomatis, nonrecommended treatment for N gonorrhoeae, and incorrect treatment of PID. Only about 25% of women and 4% of men aged 15 to 24 years who visited a physician in 1997 were tested for C trachomatis.
Increased educational efforts are required to improve physician compliance with STD screening and treatment guidelines, as well as ensure the appropriate use of STD drugs provided. Opportunities are being missed for screening for C trachomatis among young people, the majority of whom are seen regularly by a physician.
在曼尼托巴省,关于性传播疾病(STD)治疗药物的使用情况以及医生遵守STD筛查和治疗指南的程度,相关信息较少。开展本研究旨在提供此类信息,为政策和项目制定提供依据。
要求提供STD护理的医生为每位新的STD索引患者或接触者填写一份简单记录。该信息随后与省级诊断和治疗数据库中的数据相链接。
1997年10月至1998年9月期间,有2535例STD治疗报告。根据收到的治疗报告,省级卫生部门提供给医生用于STD治疗的药物中,只有约25%能够得到解释。所有治疗中,74%是对尿道或宫颈感染或盆腔炎(PID)的推定治疗,其中14.4%与随后沙眼衣原体或淋病奈瑟菌检测呈阳性有关。约四分之三的推定治疗符合省级指南,衣原体感染的大多数基于病因的治疗以及72%的淋病基于病因的治疗也符合指南。不遵守指南通常是由于仅涵盖沙眼衣原体的推定治疗、对淋病奈瑟菌的不推荐治疗以及对PID的错误治疗。1997年就诊的15至24岁女性中,只有约25%接受了沙眼衣原体检测,男性中这一比例为4%。
需要加大教育力度,以提高医生对STD筛查和治疗指南的遵守程度,并确保合理使用提供的STD药物。在年轻人中进行沙眼衣原体筛查的机会正在错失,而他们中的大多数人会定期看医生。